T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Humana
HUM
$46.7B
| $342M | 0.05% |
1,288,758
-4,061,021
| -76% | -$1.03B |
|
|
RDS.B
352
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $341M | 0.05% |
5,186,347
+49,746
| +1% | +$3.23M |
|
353
Simon Property Group
SPG
$71.4B
| $333M | 0.05% |
2,086,266
-684,365
| -25% | -$118M |
|
|
AAN.A
354
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $333M | 0.05% |
5,425,071
+421,510
| +8% | +$25.9M |
|
355
Oracle
ORCL
$442B
| $332M | 0.05% |
5,830,414
-210,594
| -3% | -$11.4M |
|
356
Terreno Realty
TRNO
$7.48B
| $332M | 0.05% |
6,767,451
+1,719
| +0% | +$77.9K |
|
357
Duke Energy
DUK
$96.3B
| $329M | 0.05% |
3,728,761
-6,650,609
| -64% | -$588M |
|
358
PPG Industries
PPG
$25.5B
| $324M | 0.05% |
2,778,999
-506,702
| -15% | -$57.8M |
|
|
PDCO
359
DELISTED
Patterson Companies, Inc.
PDCO
| $322M | 0.05% |
14,044,153
+200,464
| +1% | +$4.46M |
|
360
Southwest Gas
SWX
$6.68B
| $321M | 0.05% |
3,587,115
+205,495
| +6% | +$17.5M |
|
361
Dentsply Sirona
XRAY
$2.27B
| $319M | 0.04% |
5,471,623
+87,294
| +2% | +$4.69M |
|
362
Post Holdings
POST
$3.65B
| $318M | 0.04% |
4,670,942
-2,664,954
| -36% | -$187M |
|
363
Keurig Dr Pepper
KDP
$40.2B
| $317M | 0.04% |
10,984,429
-711,987
| -6% | -$20.3M |
|
364
Cintas
CTAS
$81.4B
| $317M | 0.04% |
5,349,140
+547,472
| +11% | +$30.3M |
|
365
Zoetis
ZTS
$30.4B
| $317M | 0.04% |
2,793,309
-524,592
| -16% | -$54.9M |
|
366
Altria Group
MO
$107B
| $316M | 0.04% |
6,677,018
-1,156,464
| -15% | -$60.6M |
|
367
Webster Financial
WBS
$12.8B
| $315M | 0.04% |
6,587,435
-3,034,336
| -32% | -$151M |
|
368
CarMax
KMX
$8.33B
| $310M | 0.04% |
3,574,056
-19,086
| -0.5% | -$1.49M |
|
369
Imperial Oil
IMO
$63.1B
| $306M | 0.04% |
11,043,637
+300,920
| +3% | +$8.44M |
|
370
Baidu
BIDU
$35.6B
| $305M | 0.04% |
2,599,128
-385,592
| -13% | -$54.9M |
|
371
Home BancShares
HOMB
$6.23B
| $305M | 0.04% |
15,815,346
-9,953
| -0.1% | -$185K |
|
372
Baxter International
BAX
$13.9B
| $304M | 0.04% |
3,712,096
-762,090
| -17% | -$59.2M |
|
373
Essex Property Trust
ESS
$18.1B
| $302M | 0.04% |
1,032,790
-20,841
| -2% | -$6.01M |
|
374
Targa Resources
TRGP
$57.6B
| $300M | 0.04% |
7,653,440
+7,495,281
| +4,739% | +$298M |
|
375
Veeva Systems
VEEV
$39.2B
| $299M | 0.04% |
1,844,299
-371,780
| -17% | -$54.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.